Speed of processing training in the ACTIVE study: how much is needed and who benefits?
- PMID: 24385640
- PMCID: PMC3947605
- DOI: 10.1177/0898264312470167
Speed of processing training in the ACTIVE study: how much is needed and who benefits?
Abstract
Objectives: Cognitive training has been shown to improve both cognitive and everyday abilities in older adults; however, little is known concerning the amount of training needed or the characteristics of those who benefit. These analyses examined the longitudinal impact of dosage (number of training sessions) on the improvement and maintenance of cognitive and everyday function.
Methods: ACTIVE is a longitudinal, randomized, single-blind clinical trial evaluating cognitive interventions in older adults (aged 65-94) from six states in the United States.
Results: Latent growth curve models indicated that initial training effects were maintained over 5 years and amplified by booster sessions. A single booster session counteracted 4.92 months of age-related processing speed decline.
Discussion: Cognitive performance improved by 2.5 standard deviations for participants who attended all 10 initial sessions and all 8 booster sessions compared to randomized participants who attended none. Implications for the broader application of cognitive training interventions are discussed.
Keywords: UFOV; activities of daily living; aging; cognitive training; driving.
Conflict of interest statement
Figures



References
-
- Ball D, Ball K, Miller R, Roenker D, White D, Griggs D. Bases for expanded functional visual fields as a result of practice. Investigative Ophthalmology and Visual Science Supplement. 1988;27:111.
-
- Ball K, Edwards JD, Ross LA. The impact of speed of processing training on cognitive and everyday functions. J Gerontol B Psychol Sci Soc Sci. 2007;62:19–31. Spec No 1. - PubMed
-
- Ball K, Owsley C, Sloane ME, Roenker DL, Bruni JR. Visual attention problems as a predictor of vehicle crashes in older drivers. Investigative Ophthalmology and Visual Science. 1993;34(11):3110–3123. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 NR004508/NR/NINR NIH HHS/United States
- U01AG14276/AG/NIA NIH HHS/United States
- U01AG14260/AG/NIA NIH HHS/United States
- U01 AG014282/AG/NIA NIH HHS/United States
- P30 AG022838/AG/NIA NIH HHS/United States
- U01AG14282/AG/NIA NIH HHS/United States
- U01AG14289/AG/NIA NIH HHS/United States
- U01NR04508/NR/NINR NIH HHS/United States
- U01 AG014289/AG/NIA NIH HHS/United States
- U01 AG014260/AG/NIA NIH HHS/United States
- U01AG14263/AG/NIA NIH HHS/United States
- 2 P30 AG022838/AG/NIA NIH HHS/United States
- U01 AG014276/AG/NIA NIH HHS/United States
- U01 AG014263/AG/NIA NIH HHS/United States
- U01NR04507/NR/NINR NIH HHS/United States
- U01 NR004507/NR/NINR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical